S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.45%) $83.47
Gas
(-1.16%) $1.619
Gold
(-0.01%) $2 346.90
Silver
(0.80%) $27.47
Platinum
(0.34%) $925.20
USD/EUR
(-0.05%) $0.934
USD/NOK
(-0.08%) $11.02
USD/GBP
(-0.07%) $0.800
USD/RUB
(0.00%) $92.17

リアルタイムの更新: Bioventix PLC [BVXP.L]

取引所: LSE 産業: Pharmaceuticals, Biotechnology & Life Sciences
最終更新日時27 4月 2024 @ 00:35

0.57% £ 4 450.00

Live Chart Being Loaded With Signals

Commentary (27 4月 2024 @ 00:35):

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications...

Stats
本日の出来高 1 387.00
平均出来高 6 543.00
時価総額 232.27M
EPS £0 ( 2024-03-24 )
Last Dividend £62.00 ( 2023-04-06 )
Next Dividend £0 ( N/A )
P/E 27.30
ATR14 £18.19 (0.41%)

Bioventix PLC 相関

10 最も正の相関
10 最も負の相関
CMET.L-0.82
ENW.L-0.81

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Bioventix PLC 財務諸表

Annual 2022
収益: £12.82M
総利益: £11.86M (92.53 %)
EPS: £1.610
FY 2022
収益: £12.82M
総利益: £11.86M (92.53 %)
EPS: £1.610
FY 2022
収益: £11.72M
総利益: £11.01M (93.94 %)
EPS: £1.470
FY 2021
収益: £10.93M
総利益: £10.11M (92.52 %)
EPS: £1.303

Financial Reports:

No articles found.

Bioventix PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£26.00
(N/A)
£0
(N/A)
£62.00
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Bioventix PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 9.02 - good (90.15%) | Divividend Growth Potential Score: 6.87 - Stable (37.33%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend £14.40 2014-10-16
Last Dividend £62.00 2023-04-06
Next Dividend £0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 18 --
Total Paid Out £610.50 --
Avg. Dividend % Per Year 1.28% --
Score 4.07 --
Div. Sustainability Score 9.02
Div.Growth Potential Score 6.87
Div. Directional Score 7.94 --
Next Divdend (Est)
(2024-10-01)
£67.26 Estimate 3.65 %
Dividend Stability
0.29 Very Poor
Dividend Score
4.07
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield
2014 £14.40 2.42%
2015 £32.60 4.47%
2016 £36.50 2.89%
2017 £60.00 4.44%
2018 £80.00 3.23%
2019 £77.00 2.51%
2020 £89.00 2.68%
2021 £81.00 1.82%
2022 £78.00 2.29%
2023 £62.00 1.50%
2024 £0 0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SGE.L Dividend Knight 2023-06-01 Semi-Annually 32 1.64%
IEML.L No Dividend Player 2023-08-10 Insufficient data to determine frequency 2 1.30%
BME.L Dividend King 2023-06-29 Semi-Annually 11 4.74%
XPP.L Dividend Knight 2023-09-07 Quarterly 18 1.72%
NWOR.L Dividend Knight 2023-06-01 Insufficient data to determine frequency 2 0.88%
ENT.L Dividend Junior 2023-08-17 Annually 19 0.58%
SRE.L Dividend Knight 2023-07-13 Semi-Annually 18 2.26%
JGGI.L Dividend King 2023-08-31 Quarterly 53 2.32%
BYIT.L Dividend Knight 2023-07-20 Annually 4 0.95%
PRSR.L Dividend Knight 2023-08-10 Quarterly 7 2.62%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.6371.50010.0010.00[0 - 0.5]
returnOnAssetsTTM0.6591.20010.0010.00[0 - 0.3]
returnOnEquityTTM0.7381.5002.924.37[0.1 - 1]
payoutRatioTTM0.915-1.0000.847-0.847[0 - 1]
currentRatioTTM7.040.80010.008.00[1 - 3]
quickRatioTTM6.690.80010.008.00[0.8 - 2.5]
cashRatioTTM3.221.50010.0010.00[0.2 - 2]
debtRatioTTM0-1.50000[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM1.5622.009.4810.00[0 - 30]
freeCashFlowPerShareTTM1.5612.009.2210.00[0 - 20]
debtEquityRatioTTM0-1.50000[0 - 2.5]
grossProfitMarginTTM0.9281.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.7891.00010.0010.00[0.1 - 0.6]
cashFlowToDebtRatioTTM01.000-1.111-1.111[0.2 - 2]
assetTurnoverTTM1.0340.8006.445.15[0.5 - 2]
Total Score9.02

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM26.801.0007.390[1 - 100]
returnOnEquityTTM0.7382.505.454.37[0.1 - 1.5]
freeCashFlowPerShareTTM1.5612.009.4810.00[0 - 30]
dividendYielPercentageTTM3.551.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.5622.009.4810.00[0 - 30]
payoutRatioTTM0.9151.5000.847-0.847[0 - 1]
pegRatioTTM281.431.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.6001.00010.000[0.1 - 0.5]
Total Score6.87

Bioventix PLC

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, infectious disease, oncology, and miscellaneous indications. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in London, the United Kingdom.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。